The Effect of Continuous, Various Doses of Furosemide Drip on Hearing as Measured by Acoustic Emission

Clalit Health Services

Status: Unknown

Conditions: Hearing Status

Study type: Observational

Funder types: Other

Identifiers

NCT00945386

005418

Details and patient eligibility

About

Pediatric patients, during their illness often treated with furosemide (Lasix) continuous drip, often, with dosages above 4-6mg/kg/day (the recommended dose).

This study will monitor hearing status of these children prior to their therapy with furosemide, during this therapy and after.

Full description

This study will record hearing status, by acoustic emission, of critically ill children, treated with different dosages of furosemide drip.

Acoustic emission test will be done prior to therapy and q48 hours during their course of treatment with furosemide drip.

Dosage of furosemide drip, boluses and other relevant medications (i.e - vancomycin, muscular relaxants, aminoglycosides etc) will be recorded.

Enrollment: 60 estimated patients

Sex: All

Ages: 1 month to 18 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• All children admitted to Pediatric ICU who are treated with furosemide continuous drip.

Exclusion criteria

• Children with known hearing abnormalities prior to treatment.